Low Dose Naltrexone by Len Saputo, MD

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
395 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Jul 26, 2011

Low dose naltrexone (LDN) has been implicated to help with cancer, HIV/AIDS, autoimmune diseases, and much more. Now it has been shown to have a potent antitumor effect on human ovarian cancer in both tissue culture and in animal xenografts. Naltrexone (NTX) is a general oioid receptor antagonist that results in compensatory elevation in endogenous oioids and opioid receptors. It has a powerful inhibition of cell lproliferation. Studies showed that LDN could also increase the effects of chemotherapy for ovarian cancer. For more information, please visit http://www.doctorsaputo.com/a/member-benefits

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (1)

Sign In or Sign Up now to post a comment!
  • I hit the wrong button. This video is very appropriate.

Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more